会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Method of isolating adult mammalian CNS-derived progenitor stem cells using density gradient centrifugation
    • 使用密度梯度离心法分离成年哺乳动物CNS来源的祖细胞干细胞的方法
    • US06767738B1
    • 2004-07-27
    • US09913192
    • 2002-02-12
    • Fred H. GageTheo PalmerFrancis G. SafarJun TakahashiMasayo Takahashi
    • Fred H. GageTheo PalmerFrancis G. SafarJun TakahashiMasayo Takahashi
    • C12N502
    • C12N5/0623A61K35/12A61K48/00C12N2501/115C12N2510/00
    • The present invention is directed to methods of repairing damaged or diseased, specialized or differentiated tissue in mature animals, particularly neuronal tissue such as retinas. In particular, the invention relates to transplantation of adult, hippocampus-derived progenitor cells into a selected neural tissue site of a recipient. These cells can functionally integrate into mature and immature neural tissue. The invention encompasses, in one aspect, repopulating a retina of a dystrophic animal with neurons, by injecting clonally derived, adult central nervous system derived stem cells (ACSC) derived from a healthy donor animal into an eye of the dystrophic recipient. Herein disclosed is the first successful and stable integration of clonally derived ACSC into same-species but different strain recipients (e. g., Fischer rat-derived adult hippocampal derived progenitor cells (AHPCs) into dystrophic RCS rats). Surprisingly, AHPCs were also found to integrate successfully into a xenogeneic recipient (e.g., rat AHPCs into the retina of dystropic rd-I mice).
    • 本发明涉及修复成熟动物特别是神经元组织如视网膜的受损或患病,专门或分化组织的方法。 特别地,本发明涉及将成年的海马衍生的祖细胞移植到接受者的所选择的神经组织部位。 这些细胞可以功能整合到成熟和未成熟的神经组织中。 本发明在一个方面包括通过将衍生自健康供体动物的克隆衍生的成体中枢神经系统干细胞(ACSC)注射到营养不良的接受者的眼睛中,将营养不良的动物的视网膜与神经元重新填充。 本文公开了克隆衍生的ACSC在相同物种但不同的菌株接收者(例如,Fischer大鼠衍生的成年海马衍生的祖细胞(AHPC))到营养不良的RCS大鼠中的第一次成功和稳定的整合。 令人惊讶的是,还发现AHPC成功地融合到异种受体(例如,大鼠AHPC进入dystropic rd-I小鼠的视网膜)中。